platelet-rich plasma + corticosteroid

Platelet-rich plasma + corticosteroid is a combination therapy involving the administration of both **platelet-rich plasma (PRP)**—a concentrated preparation from a patient's own blood containing high levels of platelets and growth factors—and a **corticosteroid**, a synthetic hormone analog with potent anti-inflammatory properties. The combination is utilized primarily in the management of various musculoskeletal and tendinous pathologies, such as tendinopathy, rotator cuff injuries, plantar fasciitis, and osteoarthritis. - **Mechanism of action:** - PRP functions primarily by delivering growth factors and cytokines that stimulate tissue repair, modulate inflammation, promote cell proliferation, and encourage matrix synthesis, aiding the regeneration of injured tissues. - Corticosteroids act mainly through reducing inflammation by inhibiting multiple inflammatory pathways and cytokine production. - The rationale for combination therapy is that PRP may offer cytoprotective and regenerative effects that could offset the deleterious long-term effects of corticosteroids on tendon and cartilage integrity, while corticosteroids provide rapid, potent symptomatic relief[5][7]. - **Indications:** Combination therapy is used off-label for musculoskeletal and soft tissue injuries, particularly where rapid symptom control and long-term tissue healing are both desired.

Other names

platelet-rich plasma plus corticosteroidPRP + corticosteroidPRP combined with corticosteroid